Genmab A/S GENMAB ORD SHS
Genmab A/S GENMAB ORD SHS/ DK0010272202 /
0MGB
|
5/24/2024 6:35:06 PM
|
Chg.
-
|
Volume |
Bid9:08:46 AM |
Ask9:08:46 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
1,926.5DKK
|
-
|
14,201
Turnover: 23.19 mill. |
1,514.0Bid Size: 2,500 |
1,578.0Ask Size: 2,500 |
102.38 bill.DKK |
- |
23.25 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
66.64 DKK |
-20.08% |
| EPS Diluted: |
- DKK |
-20.06% |
| Revenues per Share: |
249.32 DKK |
12.37% |
| Book Value per Share: |
478.40 DKK |
14.63% |
| Cash Flow per Share: |
111.69 DKK |
86.64% |
| Dividend per Share: |
- DKK |
- |
| Total |
in mill. |
|
| Revenues: |
16,474.00 DKK |
13.57% |
| Net Income: |
4,352.00 DKK |
-20.18% |
| Operating Cash Flow: |
7,380.00 DKK |
- |
| Cash and Cash Equivalents: |
14,867.00 DKK |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
23.25 |
32.34 |
| P/S Ratio: |
6.21 |
8.64 |
| P/BV ratio: |
3.24 |
4.50 |
| P/CF Ratio: |
13.87 |
19.29 |
| PEG: |
-1.16 |
-1.61 |
| Earnings Yield: |
4.30% |
3.09% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
102.38 bill. DKK |
142.39 bill. DKK |
| Free Float Market Cap.: |
- DKK |
- DKK |
| Market Cap. / Employee: |
46.45 mill. DKK |
64.61 mill. DKK |
| Shares Outstanding: |
66.07 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
32.30% |
| Net Profit Margin: |
26.42% |
| Return on Equity: |
13.77% |
| Return on Assets: |
12.33% |
Financial Strength
| Liquidity I / Cash Ratio: |
598.51% |
| Liquidity II / Quick Ratio: |
800.16% |
| Liquidity III / Current Ratio: |
1,334.10% |
| Debt / Equity Ratio: |
11.64% |
| Dynam. Debt / Equity Ratio: |
49.85% |
Efficiency
| Employees: |
2,204 |
| Personal Expenses / Employee: |
- DKK |
| Revenues / Employee: |
7,474,591.65 DKK |
| Net Income / Employee: |
1,974,591.65 DKK |
| Total Assets / Employee: |
16,011,343.01 DKK |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
